VGF and early-onset autosomal dominant Alzheimer disease: Furthermore, VGF has been suggested as a biomarker in CSF for Alzheimer’s disease (AD) and Amyotrophic lateral sclerosis (ALS) and its expression was reduced in the CSF of AD and ALS patients compared to controls (Carrette et al, 2003; Pasinetti et al, 2006).